By Rainer Shea
Read the full article from Workers Today, here.
In this era of decline for U.S. imperialist hegemony and contraction in capital, colonialism increasingly asserts itself through crude and haphazard exercises in profit-driven brutality.
By Kriston Capps
Read the full article from City Lab, here.
The Pritzker Prize-winning architect Francis Kéré uses local materials and an eye for traditional practices to push the global boundaries of sustainability.
By Joseph Choi
Read the full article from The Hill, here.
Merck has said that its pill, which targets the enzyme that allows the COVID-19 virus to make copies of itself, is likely effective against COVID-19 variants, including the highly infectious delta variant.
The U.S. government already has a supply agreement with Merck to acquire about 1.7 million courses of molnupiravir if it receives emergency use authorization from the FDA.
By Rebecca Robbins
Read the full article from The New York Times, here.
Moderna, whose coronavirus vaccine appears to be the world’s best defense against Covid-19, has been supplying its shots almost exclusively to wealthy nations, keeping poorer countries waiting and earning billions in profit.
After developing a breakthrough vaccine with the financial and scientific support of the U.S. government, Moderna has shipped a greater share of its doses to wealthy countries than any other vaccine manufacturer, according to Airfinity, a data firm that tracks vaccine shipments.
By Víctor Manuel Ramos
Read the full article from The New York Times, here.
The C.D.C.’s Covid Data Tracker, reporting results for the two-week period ending on Sept. 11, put the B.1.617.2 lineage of Delta at 99.4 percent among variants of concern, with two other Delta lineages tracked at 0.2 percent and 0.1 percent, the Mu variant — first detected in January in Colombia — at 0.1 percent and several other, unidentified variants at 0.2 percent. That data is based on thousands of sequences provided every week through the C.D.C.’s national genomic surveillance efforts, according to the agency’s website.
By Pam Belluck
Read the full article from The New York Times, here.
One year after becoming ill with the coronavirus, nearly half of patients in a large new study were still experiencing at least one lingering health symptom, adding to evidence that recovery from Covid-19 can be arduous and that the multifaceted condition known as “long Covid” can last for months.
The study, published Thursday in the journal The Lancet, is believed to be the largest to date in which patients were evaluated one year after being hospitalized for Covid. It involved 1,276 patients admitted to Jin Yin-tan Hospital in Wuhan, China, who were discharged between Jan. 7 and May 29, 2020.
By Daniel E. Slotnik and Noah Weiland
Read the full article from The New York Times, here.
As the Delta variant rages around the world, a heated debate has arisen over whether public health officials should recommend booster shots.
On one side are global health officials who contend that available vaccines would be better used to inoculate high-risk people in poor nations where few have gotten the shots.
On the other are leaders and health officials in wealthier countries, who are setting aside doses for more vulnerable people who may need additional doses to protect them from the virus.
By Benjamin Mueller and Rebecca Robbins
Read the full article from The New York Times, here.
After months of struggle, the U.N.-backed Covax alliance will soon have many more doses, promising relief for vaccine shortages in poorer countries. But it faces a deepening crisis: difficulties getting shots into arms as the Delta variant spreads.
By Max Fisher
Read the full article from New York Times, here.
A London-based public relations agency wanted to pay them to promote messages on behalf of a client. A polished three-page document detailed what to say and on which platforms to say it.
But it asked the influencers to push not beauty products or vacation packages, as is typical, but falsehoods tarring Pfizer-BioNTech’s Covid-19 vaccine. Stranger still, the agency, Fazze, claimed a London address where there is no evidence any such company exists.
By Kait Bolongaro and Niluksi Koswanage
Read the full article from Bloomberg, here.
The country will be able to welcome fully-vaccinated travelers from the U.S. as early as mid-August, and from all other countries by September, if “the current positive path of vaccination rate and public health conditions continue,” the prime minister’s office said Thursday night in a summary of his meeting with provincial leaders.